Long Island's last duck farm is quacking again after losing its entire flock to the bird flu
Within days, Crescent Duck Farm became a casualty of the global avian flu outbreak, one of many farms around the U.S. that had to cull their entire flock, sending the prices of eggs and other agricultural commodities soaring.
Now the more than century-old farm — the last duck farm remaining in a New York region once synonymous with the culinary delicacy — is cautiously rebuilding.
But for Corwin, a 66-year-old fourth-generation farmer, it's not enough to bring the farm back to its 100,000-bird capacity.
With ducks hatched from eggs spared from slaughter, he's working to preserve the unique lineage of fowl that's allowed his family's farm to thrive even as others on Long Island fell by the wayside — all while worrying that another flu outbreak would finally wipe him out.
'All I know is I don't want to be hit again,' Corwin said. 'If I go through this twice, I'm done as a duck farmer.'
Make way for ducklings
For months, Corwin and his reduced staff have been thoroughly sanitizing the farm's dozens of barns, clearing out hay and debris, and replacing feeders, ventilation systems, wooden and metal structures and more.
At the end of May, the first wave of roughly 900 young ducks arrived from a nearby farm where they had been carefully raised in quarantine these last few months.
Another batch of 900 arrived last week and some 900 more will soon make their way to the roughly 140-acre (55-hectare) farm in Aquebogue, which is tucked among the vineyards and agricultural lands of Long Island's North Fork, about 80 miles (129 km) east of Manhattan.
By the end of next summer, Corwin hopes the first ducks will be ready to be processed and brought to market.
But he says he won't rush the reopening. It will be many more months — if ever — before the operation, which processed about 1 million ducks for consumption annually, returns to full capacity, he said.
'I keep telling people I'm running a high hurdle race,' Corwin said. 'I've got a lot a lot of steps to get back to where we were.'
Bird flu pandemic still looms
Since 2022, the H5N1 strain of bird flu has been detected in all 50 states, leading to more than 1,700 recorded outbreaks affecting nearly 175 million birds, according to the most recent tally from the Centers for Disease Control and Prevention.
The outbreak at Corwin's farm shows how this strain has inflicted more damage on a wider range of species than past variants, said Dr. Gavin Hitchener, director of Cornell University's Duck Research Laboratory, located a short drive away in Eastport.
Ducks have generally been less prone to serious illness and death than chickens and turkeys, he said. H5N1 is also vexing American cattle farmers after the virus jumped from fowl to cattle last year.
'Something has changed in the virus' makeup that has made it more virulent,' Hitchener said.
With no end to the bird flu pandemic in sight, Corwin worries he won't be able to weather another outbreak.
The farm received federal compensation for its euthanized ducks, but it wasn't nearly close to the market value of the birds — never mind the expense of rebuilding in a high cost region that also includes the Hamptons, he said.
Corwin hopes the federal government will, at long last, require poultry operators to vaccinate their livestock against bird flu. It's an uphill climb, given the Trump administration's deep skepticism of vaccines and the long-standing opposition of far larger, industrial poultry operations, he acknowledged.
'I would sleep an awful lot better at night. But right now I'm very nervous,' Corwin said. 'We're just playing with deck chairs on the Titanic.'
Carrying on local heritage
The ducks newly arrived to the farm are crucial to its revival.
Fully grown and approaching breeding age, the cohort of white Pekin ducks were all that survived from the more than 15,000 eggs state officials allowed the farm to spare from the winter culling after they tested negative for bird flu.
That means they and their progeny carry on the unique genetic makeup the farm has honed over generations of selective breeding to build its reputation.
Established in 1908 by Corwin's great-grandfather, Crescent Duck Farms has been the island's lone commercial duck operation for the better part of a decade. But in the early 1960s, Long Island boasted more than 100 farms producing about two-thirds of the nation's duck output.
'I feel I owe it to the ancestors of farmers who've been here all these years and have come this far to just make a go of it,' Corwin said. 'I want to make Long Island proud.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Atlantic
18 minutes ago
- Atlantic
COVID Revenge Is Supercharging the Anti-Vaccine Agenda
Four and a half years ago, fresh off the success of Operation Warp Speed, mRNA vaccines were widely considered—as President Donald Trump said in December 2020 —a 'medical miracle.' Last week, the United States government decidedly reversed that stance when Secretary of Health and Human Services Robert F. Kennedy Jr. canceled nearly half a billion dollars' worth of grants and contracts for mRNA-vaccine research. With Kennedy leading HHS, this about-face is easy to parse as yet another anti-vaccine move. But the assault on mRNA is also proof of another kind of animus: the COVID-revenge campaign that top officials in this administration have been pursuing for months, attacking the policies, technologies, and people that defined the U.S.'s pandemic response. As the immediacy of the COVID crisis receded, public anger about the American response to it took deeper root—perhaps most prominently among some critics who are now Trump appointees. That acrimony has become an essential tool in Kennedy's efforts to undermine vaccines. 'It is leverage,' Dorit Reiss, a vaccine-law expert at UC Law San Francisco, told me. 'It is a way to justify doing things that he wouldn't be able to get away with otherwise.' COVID revenge has defined the second Trump administration's health policy from the beginning. Kennedy and his allies have ousted prominent HHS officials who played key roles in the development of COVID policy, as well as scientists at the National Institutes of Health, including close colleagues of Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases (and, according to Trump, an idiot and a 'disaster'). In June, Kennedy dismissed every member of the CDC Advisory Committee on Immunization Practices (ACIP), which has helped shape COVID-vaccine recommendations, and handpicked replacements for them. HHS and ACIP are now stacked with COVID contrarians who have repeatedly criticized COVID policies and minimized the benefits of vaccines. Under pressure from Trump officials, the NIH has terminated funding for hundreds of COVID-related grants. The president and his appointees have espoused the highly disputed notion that COVID began as a leak from 'an unsafe lab in Wuhan, China'—and cited the NIH's funding of related research as a reason to restrict federal agencies' independent grant-awarding powers. This administration is rapidly rewriting the narrative of COVID vaccines as well. In an early executive order, Trump called for an end to COVID-19-vaccine mandates in schools, even though few remained; earlier this month, HHS rolled back a Biden-era policy that financially rewarded hospitals for reporting staff-vaccination rates, describing the policy as ' coercive.' The FDA has made it harder for manufacturers to bring new COVID shots to market, narrowed who can get the Novavax shot, and approved the Moderna COVID-19 vaccines for only a limited group of children, over the objections of agency experts. For its part, the CDC softened its COVID-shot guidance for pregnant people and children, after Kennedy—who has described the shots as 'the deadliest vaccine ever made'—tried to unilaterally remove it. Experts told me they fear that what access remains to the shots for children and adults could still be abolished; so could COVID-vaccine manufacturers' current protection from liability. (Andrew Nixon, an HHS spokesperson, said in an email that the department would not comment on potential regulatory changes.) The latest assault against mRNA vaccines, experts told me, is difficult to disentangle from the administration's pushback on COVID shots—which, because of the pandemic, the public now views as synonymous with the technology, Jennifer Nuzzo, the director of the Pandemic Center at Brown University School of Public Health, told me. Kennedy justified the mRNA cuts by suggesting—in contrast to a wealth of evidence—that the vaccines' risks outweigh their benefits, and that they 'fail to protect effectively against upper respiratory infections like COVID and flu.' And he insisted, without proof, that mRNA vaccines prolong pandemics. Meanwhile, NIH Director Jay Bhattacharya argued that the cancellations were driven by a lack of public trust in the technology itself. In May, the Trump administration also pulled more than $700 million in funds from Moderna that had initially been awarded to develop mRNA-based flu vaccines. The mRNA funding terminated so far came from HHS's Biomedical Advanced Research and Development Authority; multiple NIH officials told me that they anticipate that similar grant cuts will follow at their agency. (In an email, Kush Desai, a spokesperson for the White House, defended the administration's decision as a way to prioritize funding with 'the most untapped potential'; Nixon echoed that sentiment, casting the decision as 'a necessary pivot in how we steward public health innovations in vaccines.') COVID is a politically convenient entryway to broader anti-vaccine sentiment. COVID shots are among the U.S.'s most politicized vaccines, and many Republicans have, since the outbreak's early days, been skeptical of COVID-mitigation policies. Although most Americans remain supportive of vaccines on the whole, most Republicans—and many Democrats—say they're no longer keen on getting more COVID shots. 'People trust the COVID vaccines less,' Nuzzo told me, which makes it easy for the administration's vaccine opponents to use attacks on those vaccines as purchase for broader assaults. For all their COVID-centric hype, mRNA vaccines have long been under development for many unrelated diseases. And experts now worry that the blockades currently in place for certain types of mRNA vaccines could soon extend to other, similar technologies, including mRNA-based therapies in development for cancer and genetic disease, which might not make it through the approval process at Kennedy's FDA. (Nixon said HHS would continue to invest in mRNA research for cancer and other complex diseases.) Casting doubt on COVID shots makes other vaccines that have been vetted in the same way—and found to be safe and effective, based on high-quality data—look dubious. 'Once you establish that it's okay to override something for COVID,' Reiss told me, 'it's much easier to say, 'Well, now we're going to unrecommend MMR.'' (Kennedy's ACIP plans to review the entire childhood-immunization schedule and assess its cumulative effects.) Plenty of other avenues remain for Kennedy to play on COVID discontent—fear of the shots' side effects, distaste for mandates, declining trust in public health and medical experts —to pull back the government's support for vaccination. He has announced, for instance, his intention to reform the Vaccine Injury Compensation Program, which helps protect manufacturers from lawsuits over illegitimate claims about a vaccine's health effects, and his plans to find 'ways to enlarge that program so that COVID-vaccine-injured people can be compensated.' Some of the experts I spoke with fear that the FDA's Vaccines and Related Biological Products Advisory Committee—the agency's rough equivalent of ACIP—could be remade in Kennedy's vision. The administration has also been very willing to rescind federal funding from universities in order to forward its own ideas: Kennedy could, perhaps, threaten to withhold money from universities that require any vaccines for students. Kennedy has also insisted that 'we need to stop trusting the experts'—that Americans, for instance, shouldn't have been discouraged from doing their own research during the pandemic. He could use COVID as an excuse to make that maxim Americans' reality: Many public-health and infectious-disease-focused professional societies rely on at least some degree of federal funding, Nirav D. Shah, a former principal deputy director of the CDC, told me. Stripping those resources would be 'a way to cut their legs off'—or, at the very least, would further delegitimize those expert bodies in the public eye. Kennedy has already barred representatives from professional societies, including the American Academy of Pediatrics and the Infectious Diseases Society of America, from participating in ACIP subcommittees after those two societies and others collectively sued HHS over its shifts in COVID policy. The public fight between medicine and government is now accelerating the nation onto a path where advice diverges over not just COVID shots but vaccines generally. (When asked about how COVID resentment was guiding the administration's decisions, Desai said that the media had politicized science to push for pandemic-era mandates and that The Atlantic 'continues to fundamentally misunderstand how the Trump administration is reversing this COVID era politicization of HHS.') The coronavirus pandemic began during the first Trump presidency; now its legacy is being exploited by a second one. Had the pandemic never happened, Kennedy would likely still be attacking vaccines, maybe even from the same position of power he currently commands. But without the lightning rod of COVID, Kennedy's attacks would be less effective. Already, one clear consequence of the Trump administration's anti-COVID campaign is that it will leave the nation less knowledgeable about and less prepared against all infectious diseases, Gregory Poland, a vaccinologist and the president of Atria Research Institute, told me. That might be the Trump administration's ultimate act of revenge. No matter who is in charge when the U.S. meets its next crisis, those leaders may be forced into a corner carved out by Trump and Kennedy—one from which the country must fight disease without adequate vaccination, research, or public-health expertise. This current administration will have left the nation with few other options.
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Sudan launches a 10-day cholera vaccination campaign in Khartoum as war continues
KHARTOUM, Sudan (AP) — Health officials in Sudan have launched a 10-day cholera vaccination campaign in the capital, Khartoum, to curb what humanitarians call a rapidly spreading outbreak of the diarrheal disease fueled by civil war, displacement and heavy rainfall. Associated Press video footage on Wednesday showed officials administering the vaccine to children and others. Healthcare worker Aziza Berima said the campaign in Khartoum began Sunday and targets over 150,000 people. Resident Montaser al-Sayed said he and his family recently returned home after being displaced by fighting. They feared cholera in the chaotic conditions but said the vaccination campaign reassured them. 'As a mother, I was relieved," said another resident, Razaz Abdullah. Cholera is spreading at an alarming rate and the collapsed health system makes it "extremely hard to trace and contain,' Sophie Dresser, director of programs at Mercy Corps-Sudan, told the AP. Last month, the United Nations humanitarian office said over 32,000 suspected cholera cases have been reported in Sudan this year. Since the outbreak was declared in July 2024, more than 83,000 cases and 2,100 deaths have been reported, the U.N. said, citing Sudan's health ministry. The U.N. says cases are rising in Sudan's more remote western region of Darfur. The health ministry has reported 1,440 suspected cases and 74 deaths there. Although vaccination campaigns launched last year across some areas in Sudan, the disease has continued to spread in recent months amid the ongoing fighting between the paramilitary Rapid Support Forces and the Sudanese army. The civil war erupted in April 2023 in Khartoum before spreading across the country. The fighting has killed over 40,000 people, displaced as many as 12 million and pushed many to the brink of famine. The World Health Organization describes cholera as a 'disease of poverty' because it spreads where there is poor sanitation and a lack of clean water. The diarrheal disease is caused when people eat food or water contaminated with the bacterium Vibrio cholerae. It is easily treatable with rehydration solutions and antibiotics, but in severe cases the disease can kill within hours if left untreated. A spike in cholera cases had been reported in Khartoum, where 172 people died and more than 2,500 others were infected in a week in late May. A 10-day vaccination campaign at the time reached over 2.2 million people, the WHO reported in July.
The Hill
an hour ago
- The Hill
Alcohol drinking rate at record low: Gallup
Only 54 percent of American adults say they consume alcohol, according to Gallup, the lowest in the survey's 90-year history by one percentage point. The low metric was repeated across several demographic angles, including gender, race and age. Fifty-seven percent of men reported drinking alcohol, compared to 51 percent of women. White adults (56 percent) were four points more likely to drink than people of color (52 percent). Adults aged 35 and older (about 56 percent) were also more likely to drink than their younger counterparts (50 percent). Gallup's findings, however, varied widely by income level, consistent with previous years. Less than 40 percent of people with an annual household income of less than $40,000 reported drinking, compared to 53 percent just two years ago. About two-thirds of Americans making over $100,000 a year reported drinking — also a substantial dip from 79 percent just two years ago. Gallup's poll also found that a majority of Americans, 53 percent, say drinking in moderation ('one or two drinks a day') is bad for one's health. In 2018, only 28 percent of respondents made that claim. That perception is dominated by young people aged 18 to 34, 66 percent of whom thought drinking in moderation was detrimental to their health. The poll's findings come amid a growing shift in beliefs about whether moderate drinking, or even drinking altogether, has beneficial health effects. A series of new studies in recent years have pointed to increasing evidence that alcohol consumption is linked to cancer and other adverse health effects. The Gallup poll was conducted July 7–21. The sample size and margin of error were unclear.
